Eribulin

Open Access
HT1080 Human Fibrosarcoma Cells Selected for Super-eribulin Resistance In Vitro Become More Malignant and Are Arrested Synergistically by Methionine Restriction in Combination With Eribulin in Nude Mice
SEI MORINAGA, KOHEI MIZUTA, BYUNG MO KANG, QINGHONG HAN, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN

In Vivo May 2025, 39 (3) 1275-1282; DOI: https://doi.org/10.21873/invivo.13931
Open Access
Chemotherapy With Eribulin Following Potentially Curative Surgery in Patients With Localized Liposarcoma
OSKAR STEINBRECHER, THOMAS BRODOWICZ, PETAR POPOV and WOLFGANG LAMM

In Vivo January 2024, 38 (1) 385-389; DOI: https://doi.org/10.21873/invivo.13450
Open Access
Risk Factors for Eribulin-induced Severe Neutropenia in Patients With Recurrent Breast Cancer
SHINYA TAKADA, YOSHIHIRO HOSOKAWA, KENGO UMEHARA, YUTA KIMURA, YUTA FUKAI, KARIN SHIKISHIMA, MITSUGU YAMAMOTO, HIDEKI MAEDA, NOBUMOTO TOMIOKA, KENICHI WATANABE and HIROKAZU HASHISHITA

In Vivo January 2024, 38 (1) 500-505; DOI: https://doi.org/10.21873/invivo.13466
Open Access
Optimal Prognostic Factors for Metastatic and Inoperable Sarcomas Treated With Pazopanib, Eribulin, and Trabectedin
TADASHI IWAI, MANABU HOSHI, NAOTO OEBISU, NAOKI TAKADA, YOSHITAKA BAN, HANA YAO and HIROAKI NAKAMURA

In Vivo November 2023, 37 (6) 2634-2641; DOI: https://doi.org/10.21873/invivo.13371
Open Access
The Modified Glasgow Prognostic Score and Prognostic Nutritional Index as Prognostic Markers in Patients With Metastatic Breast Cancer Treated With Eribulin
SHINYA YAMAMOTO, SHOKO ADACHI, TOMOKO WADA, KAZUTAKA NARUI, AKI KIMURA, MASANORI OSHI, AKIMITSU YAMADA, TOSHIHIRO MISUMI and ITARU ENDO

In Vivo July 2022, 36 (4) 1854-1859; DOI: https://doi.org/10.21873/invivo.12903
You have access
Osteosarcoma of the Breast in a Patient Derived Orthotopic Xenograft (PDOX) Mouse Model Is Arrested by both Cisplatinum and Eribulin
NORIYUKI MASAKI, NATHANIEL F. WU, YUSUKE AOKI, JUN YAMAMOTO, JUN MIYAZAKI and ROBERT M. HOFFMAN

In Vivo November 2021, 35 (6) 3107-3110; DOI: https://doi.org/10.21873/invivo.12605
You have access
Efficacy of Oral Recombinant Methioninase and Eribulin on a PDOX Model of Triple-negative Breast Cancer (TNBC) Liver Metastasis
HYE IN LIM, YU SUN, QINGHONG HAN, JUN YAMAMOTO and ROBERT M. HOFFMAN

In Vivo September 2021, 35 (5) 2531-2534; DOI: https://doi.org/10.21873/invivo.12534
You have access
Eribulin Suppresses New Metastases in Patients With Metastatic Breast Cancer
TAKAAKI FUJII, SHOKO TOKUDA, YUKO NAKAZAWA, SASAGU KUROZUMI, SAYAKA OBAYASHI, REINA YAJIMA and KEN SHIRABE

In Vivo March 2020, 34 (2) 917-921; DOI: https://doi.org/10.21873/invivo.11858

Main menu

User menu

Search

Eribulin